These figures do not represent guaranteed BreezeMeds outcomes, do not apply specifically to compounded formulations, and cannot predict any individual result
Participants were prescribed a reduced-calorie diet (500-kcal/d deficit relative to estimated energy expenditure calculated at week 0) and increased physical activity (150 min/wk), recorded daily by participants (using paper diaries, apps, or other tools) and reviewed during counseling visits
However, KPV's comparative lack of side effects suggests its potential as a research alternative, albeit with slightly reduced potency

In 2021, approximately 537 million adults worldwide were diagnosed with diabetes, and this number is projected to rise to 783 million by 2045 ( Beyond its metabolic consequences, cigarette smoking is causally associated with chronic obstructive pulmonary disease, interstitial lung disease ( Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used in the treatment of T2DM due to their glucose-lowering efficacy and beneficial effects on body weight ( A recent large-scale real-world observational study using target trial emulation reported an association between semaglutide use and a reduced risk of tobacco use disorder in patients with T2DM ( Therefore, this randomized controlled trial aims to investigate the effects of GLP-RA on nicotine dependence and smoking-related outcomes in patients with T2DM, and to explore potential neural mechanisms using functional magnetic resonance imaging (fMRI)

Treatment satisfaction in people with type 2 diabetes mellitus treated with once-weekly dulaglutide: data from the AWARD-1 and AWARD-3 clinical trials